Gilead Sciences’ Indian patent request for hepatitis C drug sofosbuvir faces opposition Gilead Sciences’ Indian patent request for hepatitis C drug sofosbuvir faces opposition – I-MAK

Gilead Sciences’ Indian patent request for hepatitis C drug sofosbuvir faces opposition

Media Article 25 Nov 2013

Partner with us now to build
a more just and equitable
medicine system for all.